Zentalis Pharmaceuticals, Inc. (ZNTL) Tops Q3 EPS by 16c
Tweet
Share
E-mailGet Alerts ZNTL Hot Sheet
Join SI Premium – FREE
Zentalis Pharmaceuticals, Inc. (NASDAQ: ZNTL) reported Q3 EPS of ($0.37), $0.16 better than the analyst estimate of ($0.53).
For earnings history and earnings-related data on Zentalis Pharmaceuticals, Inc. (ZNTL) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Arm Holdings falls as CFO stock sale weighs on sentiment
- Increasing unusual put option volume: WHR MDB ALT HUBS ILMN CBRL SMMT CG KMX
- Bloom Energy shares fall on Oracle project halt
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
